The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases

MLA

Andrew Carvalho, et al. “The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals Its Therapeutic Potential in Neurodegenerative Diseases.” Frontiers in Pharmacology, vol. 12, May 2021. EBSCOhost, https://doi.org/10.3389/fphar.2021.656561/full.

APA

Andrew Carvalho, Kim Tang, Christopher J. Winrow, John R. Hadcock, Sarah Jacobson, Jenny Tobin, Elisabeth Lonie, Sylvie G. Bernier, Thomas W.-H. Lee, Susana S. Correia, Rennie Glen Robert, Chad D. Schwartzkopf, Joon Jung, Peter Germano, Guang Liu, Juli E. Jones, Mark G. Currie, Paul Allan Renhowe, & Rajesh R. Iyengar. (2021). The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.656561/full

Chicago

Andrew Carvalho, Kim Tang, Christopher J. Winrow, John R. Hadcock, Sarah Jacobson, Jenny Tobin, Elisabeth Lonie, et al. 2021. “The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals Its Therapeutic Potential in Neurodegenerative Diseases.” Frontiers in Pharmacology 12 (May). doi:10.3389/fphar.2021.656561/full.